FDA Beats Ranbaxy Suit Despite 'Serious' Approval Errors
March 11, 2015
Jeff Overley
Law360
Axinn Partner Chad Landmon was quoted in the Law360 article, "FDA Beats Ranbaxy Suit Despite 'Serious' Approval Errors."
Click here to access the article. A Law360 subscription is required.